Semmineh N, Bell L, Stokes A, Hu L, Boxerman J, Quarles C
AJNR Am J Neuroradiol. 2018; 39(11):1981-1988.
PMID: 30309842
PMC: 6239921.
DOI: 10.3174/ajnr.A5827.
Abramson R, Arlinghaus L, Dula A, Quarles C, Stokes A, Weis J
Magn Reson Imaging Clin N Am. 2015; 24(1):11-29.
PMID: 26613873
PMC: 4667554.
DOI: 10.1016/j.mric.2015.08.002.
Gordon Y, Partovi S, Muller-Eschner M, Amarteifio E, Bauerle T, Weber M
Cardiovasc Diagn Ther. 2014; 4(2):147-64.
PMID: 24834412
PMC: 3996240.
DOI: 10.3978/j.issn.2223-3652.2014.03.01.
Pavlisa G, Pavlisa G, Rados M
Radiol Oncol. 2012; 45(2):97-101.
PMID: 22933942
PMC: 3423727.
DOI: 10.2478/v10019-011-0011-x.
Quarles C, Gore J, Xu L, Yankeelov T
Magn Reson Imaging. 2012; 30(7):944-53.
PMID: 22617148
PMC: 3569857.
DOI: 10.1016/j.mri.2012.03.008.
MR molecular imaging of tumor vasculature and vascular targets.
Pathak A, Penet M, Bhujwalla Z
Adv Genet. 2010; 69:1-30.
PMID: 20807600
PMC: 4921063.
DOI: 10.1016/S0065-2660(10)69010-4.
In vivo validation of MRI vessel caliber index measurement methods with intravital optical microscopy in a U87 mouse brain tumor model.
Farrar C, Kamoun W, Ley C, Kim Y, Kwon S, Dai G
Neuro Oncol. 2010; 12(4):341-50.
PMID: 20308312
PMC: 2940602.
DOI: 10.1093/neuonc/nop032.
Molecular Imaging of Cancer: Applications of Magnetic Resonance Methods.
Gimi B, Pathak A, Ackerstaff E, Glunde K, Artemov D, Bhujwalla Z
Proc IEEE Inst Electr Electron Eng. 2011; 93(4):784-799.
PMID: 19779604
PMC: 2749700.
DOI: 10.1109/JPROC.2005.844266.
A theoretical framework to model DSC-MRI data acquired in the presence of contrast agent extravasation.
Quarles C, Gochberg D, Gore J, Yankeelov T
Phys Med Biol. 2009; 54(19):5749-66.
PMID: 19729712
PMC: 2767268.
DOI: 10.1088/0031-9155/54/19/006.
Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors.
Paulson E, Schmainda K
Radiology. 2008; 249(2):601-13.
PMID: 18780827
PMC: 2657863.
DOI: 10.1148/radiol.2492071659.
Perfusion imaging of meningioma by using continuous arterial spin-labeling: comparison with dynamic susceptibility-weighted contrast-enhanced MR images and histopathologic features.
Kimura H, Takeuchi H, Koshimoto Y, Arishima H, Uematsu H, Kawamura Y
AJNR Am J Neuroradiol. 2006; 27(1):85-93.
PMID: 16418363
PMC: 7976105.
Characterization of a first-pass gradient-echo spin-echo method to predict brain tumor grade and angiogenesis.
Schmainda K, Rand S, Joseph A, Lund R, Ward B, Pathak A
AJNR Am J Neuroradiol. 2004; 25(9):1524-32.
PMID: 15502131
PMC: 7976425.
Perfusion MR imaging in gliomas: comparison with histologic tumor grade.
Lee S, Kim J, Kim Y, Lee G, Lee E, Park I
Korean J Radiol. 2001; 2(1):1-7.
PMID: 11752962
PMC: 2718089.
DOI: 10.3348/kjr.2001.2.1.1.
A CT method to measure hemodynamics in brain tumors: validation and application of cerebral blood flow maps.
Cenic A, Nabavi D, Craen R, Gelb A, Lee T
AJNR Am J Neuroradiol. 2000; 21(3):462-70.
PMID: 10730636
PMC: 8174983.
Comparison of relative cerebral blood volume and proton spectroscopy in patients with treated gliomas.
Henry R, Vigneron D, Fischbein N, Grant P, Day M, Noworolski S
AJNR Am J Neuroradiol. 2000; 21(2):357-66.
PMID: 10696024
PMC: 7975338.
Functional imaging of the brain in the evaluation of drug response and its application to the study of aging.
Bryant C, Jackson S
Drugs Aging. 1998; 13(3):211-22.
PMID: 9789725
DOI: 10.2165/00002512-199813030-00004.
Ultra-high-speed MR imaging.
Davis C, McKinnon G, Debatin J, von Schulthess G
Eur Radiol. 1996; 6(3):297-311.
PMID: 8797999
DOI: 10.1007/BF00180599.